Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End Points.
Robert RosensonYuxi LiuMichael K HansenYshai YavinNaveed SattarCarol A PollockJaved ButlerMeg J JardineSerge MassonHiddo J Lambers HeerspinkJames L JanuzziPublished in: Clinical journal of the American Society of Nephrology : CJASN (2023)
Higher Angiopoietin 2 levels were associated with cardiorenal risk among individuals with diabetic kidney disease independent of VEGF-A. Canagliflozin lowered angiopoietin 2 concentrations.